Just Released - Transplantation - July 2023 Issue
Around the World
Research Highlights
Game Changer
People in Transplantation
- Sir Peter J. Morris, AC, FRS, FMedSci, FRCP, FRCS
- There Is a Lot More to Transplantation Surgery Than the Surgery Itself: The “Other” Sir Peter John Morris, AC, FRS
Special Feature
Commentaries
- Comments on: Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma
- Prioritizing the Sickest Among the Sickest: A Matter of Tact and Moderation, but the Game Is Worth the Candle
- Baby Steps Taken in Developing an Understanding of the Long-term Health Consequences of Pregnancy Complications in Living Kidney Donors
Reviews
- Expanding Donor Options for Lung Transplant: Extended Criteria, Donation After Circulatory Death, ABO Incompatibility, and Evolution of Ex Vivo Lung Perfusion
- Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients With Advanced Skin Cancers—Emerging Strategies for Clinical Management
- The Utility of Spatial Transcriptomics for Solid Organ Transplantation
- CD40-CD40L Blockade: Update on Novel Investigational Therapeutics for Transplantation
- Caregiver Burden in Adult Solid Organ Transplantation
Original Basic Science
- Therapeutic Effects of Anti-PD1 Immunotherapy on Hepatocellular Carcinoma Under Administration of Tacrolimus
- Subset-specific Retention of Donor Myeloid Cells After Major Histocompatibility Complex-matched and Mismatched Liver Transplantation
Original Clinical Science—Liver
- Modern Outcomes After Liver Retransplantation: A Single-center Experience
- Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma
- Late-onset Chronic Kidney Disease Over 2 Decades After Pediatric Liver Transplantation: A Single-center, Retrospective Study
- Physical Performance Decline During the Early Posttransplantation Period Affects Survival After Living Donor Liver Transplantation
Original Clinical Science—General
- Optimal Donor Allograft Function: The Search for the Lowest Acceptable Donor Left Ventricular Ejection Fraction in Pediatric Heart Transplantation
- The Outcome of Transplanting Kidneys From Very Small Pediatric Deceased Donors
- Intraoperative Red Blood Cell Transfusion and Primary Graft Dysfunction After Lung Transplantation
- Natural Antibodies Are Associated With Rejection and Long-term Renal Allograft Loss in a Multicenter International Cohort
- Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis From TRANSFORM Study
- Temporary Mechanical Circulatory Support Use and Clinical Outcomes of Simultaneous Heart/Kidney Transplant Recipients in the Pre– and Post–heart Allocation Policy Change Eras
- Long-term Outcomes Associated With Post–kidney Donation Pregnancy Complications
- Primary Graft Dysfunction Is Associated With Development of Early Cardiac Allograft Vasculopathy, but Not Other Immune-mediated Complications, After Heart Transplantation
- Multicenter Validation of a Urine CXCL10 Assay for Noninvasive Monitoring of Renal Transplants
Letter to the Editor
MESOT 2023 Videos and Photos now available!
MESOT Members and Attendees
will be provided access with two weeks
Dear Colleagues,
With the conclusion of the 18th Congress of the Middle East Society for Organ Transplantation (MESOT 2023) that took place on May 24-26, 2023, I would like to express my sincere appreciation for those who attended and contributied at the meeting.
From its inception, the goals of MESOT have been to encourage the development of scientifically and ethically superior organ transplantation activities across the globe. Therefore, The MESOT International Congress is the major international transplant congress and attracts a broad range of health professionals.
MESOT 2023 Congress which was endorsed by The Transplantation Society (TTS), The Turkish Transplantation Society (TOND) and The Turkic World Transplantation Society (TDTD) proved to be a great success, with high positive feedback from all who were in attendance. The total number of registrations for the MESOT Congress was 320 from 38 countries. A total of 55 Invited Lectures, 38 Oral and 116 Poster Presentations were scheduled for the congress.
The scientific program incorporated a wide range of topics designed to provide an innovative and comprehensive overview of the latest developments in the field of experimental and clinical transplantation in the Middle East and the world. I hope it has provided valuable insights for our colleagues in the transplant field across the globe.
Once again, thank you for your support it was an honor to host this important Congress.
Sincerely,
Mehmet Haberal, MD, FACS (Hon), FICS (Hon),
FASA (Hon), FIMSA (Hon), Hon FRCS (Glasg)
Founder and Past-President, MESOT
Congress Chair, 18th Congress of the Middle East Society for Organ Transplantation
SPLIT 2023 - Awards and Program Update
AWARDS - Submit an abstract and apply for an award!
Award winners will have the opportunity to present their research in either poster or oral presentation, receive free SPLIT Annual Meeting registration, a grant for reimbursable travel expenses up to $1000 and networking opportunities. We are offering two types of awards
- SPLIT – TTS Travel Grants for Trainees, Junior Faculty, and Multi-disciplinary Team Members.
- Albireo, an Ipsen Company, and Mirum Travel Grants for Medical Students, Pediatrics Residents, Surgery Residents and Pediatric Gastroenterology fellows identifying as Underrepresented in Medicine
Program Spotlight - October 16 Afternoon Sessions
Transplantation Updates
Transplantation - Highlighted Tweets
Transplantation Direct - Highlighted Tweet
CIRTA 2023 - One Week Away!
In case you missed it ... ITS Meeting Recordings Are Now Available!
A special thanks to our important partners AST and ESOT for making this meeting a tremendous success!
Contact
Address
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada